Corrigendum to ‘Central Nervous System Progression in Patients Receiving ALK-Targeted Central Nervous System–Penetrable Tyrosine Kinase Inhibitors: Treatment Patterns and Outcomes’ [JTO Clinical and Research Reports 6 (2025) 100914]
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Fields of Study & Subjects
Publication details
- Journal / source
- JTO Clinical and Research Reports
- Volume
- 7
- Issue
- 6
- Pages
- 100992–100992
- Publication date
- 20 March 2026
- Language
- EN